These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14552327)

  • 21. Cyclooxygenase-2 in Barrett's esophagus, Barrett's adenocarcinomas, and esophageal SCC: ready for clinical trials.
    Lord RV; Danenberg KD; Danenberg PV
    Am J Gastroenterol; 1999 Aug; 94(8):2313-5. PubMed ID: 10445576
    [No Abstract]   [Full Text] [Related]  

  • 22. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC; Kania J; Burnat G; Hahn EG
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus.
    Wilson KT
    Dis Esophagus; 2002; 15(1):16-21. PubMed ID: 12060038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
    Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW
    J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Barrett's esophageal adenocarcinoma].
    Nakamura T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):322-6. PubMed ID: 15045933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical strategy for the Barrett's esophagus].
    Kitabatake S; Niwa Y; Goto H
    Nihon Rinsho; 2005 Aug; 63(8):1434-7. PubMed ID: 16101235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.
    van der Woude CJ; Jansen PL; Tiebosch AT; Beuving A; Homan M; Kleibeuker JH; Moshage H
    Hum Pathol; 2002 Jul; 33(7):686-92. PubMed ID: 12196918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract.
    Dannenberg AJ; Altorki NK; Boyle JO; Lin DT; Subbaramaiah K
    Ann N Y Acad Sci; 2001 Dec; 952():109-15. PubMed ID: 11795429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
    Cheong E; Ivory K; Doleman J; Parker ML; Rhodes M; Johnson IT
    Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin inhibitors and the chemoprevention of noncolonic malignancy.
    Krishnan K; Brenner DE
    Gastroenterol Clin North Am; 2001 Dec; 30(4):981-1000. PubMed ID: 11764539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2 inhibition in upper aerodigestive tract tumors.
    Altorki NK; Subbaramaiah K; Dannenberg AJ
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):30-6. PubMed ID: 15252927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of prostaglandinE2 via bile acid is enhanced by trypsin and acid in normal human esophageal epithelial cells.
    Kawabe A; Shimada Y; Soma T; Maeda M; Itami A; Kaganoi J; Kiyono T; Imamura M
    Life Sci; 2004 May; 75(1):21-34. PubMed ID: 15102519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclo-oxygenase-2 expression in Barrett's oesophageal carcinogenesis: an immunohistochemical study.
    Cheong E; Igali L; Harvey I; Mole M; Lund E; Johnson IT; Rhodes M
    Aliment Pharmacol Ther; 2003 Feb; 17(3):379-86. PubMed ID: 12562450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus.
    Majka J; Wierdak M; Szlachcic A; Magierowski M; Targosz A; Urbanczyk K; Krzysiek-Maczka G; Ptak-Belowska A; Bakalarz D; Magierowska K; Chmura A; Brzozowski T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G375-G389. PubMed ID: 31928220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis.
    Lanas A; Jiménez P; Ferrández A; Escartín A; Arenas J; Esteva F; Ortego J
    Inflammation; 2003 Feb; 27(1):21-9. PubMed ID: 12772774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.
    Buskens CJ; Van Rees BP; Sivula A; Reitsma JB; Haglund C; Bosma PJ; Offerhaus GJ; Van Lanschot JJ; Ristimäki A
    Gastroenterology; 2002 Jun; 122(7):1800-7. PubMed ID: 12055587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
    Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
    Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancer.
    Ling FC; Baldus SE; Khochfar J; Xi H; Neiss S; Brabender J; Metzger R; Drebber U; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Histopathology; 2007 Jan; 50(2):203-9. PubMed ID: 17222248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.